Cargando…
Lynch Syndrome and Gynecologic Tumors: Incidence, Prophylaxis, and Management of Patients with Cancer
SIMPLE SUMMARY: Lynch syndrome (LS) is a genetic condition predisposing to a variety of tumors, including endometrial (EC) and ovarian cancers (OC), with cancer lifetime risk depending on the specific LS-mutation involved. Universal Screening is the standard for LS detection. Prophylactic surgery is...
Autores principales: | Capasso, Ilaria, Santoro, Angela, Lucci Cordisco, Emanuela, Perrone, Emanuele, Tronconi, Francesca, Catena, Ursula, Zannoni, Gian Franco, Scambia, Giovanni, Fanfani, Francesco, Lorusso, Domenica, Duranti, Simona |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10000861/ https://www.ncbi.nlm.nih.gov/pubmed/36900193 http://dx.doi.org/10.3390/cancers15051400 |
Ejemplares similares
-
Fertility-sparing treatment for endometrial cancer and atypical endometrial hyperplasia in patients with Lynch Syndrome: Molecular diagnosis after immunohistochemistry of MMR proteins
por: Catena, Ursula, et al.
Publicado: (2022) -
Further refining 2020 ESGO/ESTRO/ESP molecular risk classes in patients with early‐stage endometrial cancer: A propensity score–matched analysis
por: Nero, Camilla, et al.
Publicado: (2022) -
Cost-effectiveness analysis of genetic diagnostic strategies for Lynch syndrome in Italy
por: Pastorino, Roberta, et al.
Publicado: (2020) -
Immunotherapy in gynecological cancers
por: Lorusso, Domenica, et al.
Publicado: (2021) -
Adjuvant Treatment Recommendations in Early-Stage Endometrial Cancer: What Changes With the Introduction of The Integrated Molecular-Based Risk Assessment
por: Nero, Camilla, et al.
Publicado: (2021)